Comparar métodos
Examine os métodos selecionados lado a lado; as linhas que diferem ficam destacadas.
| Escala de Autoeficácia para Diabetes (DASES)× | Questionário de Medo de Hipoglicemia (HFS)× | |
|---|---|---|
| Área | Cardiologia | Cardiologia |
| Família | Process / pipeline | Process / pipeline |
| Ano de origem≠ | 2009 | 1987 |
| Autor original≠ | Kate Lorig | Daniel J. Cox |
| Tipo | Self-report questionnaire | Self-report questionnaire |
| Fonte seminal≠ | Lorig, K. R., Ritter, P. L., Villa, F. J., & Armas, J. (2009). Community-based peer-led diabetes self-management: A randomized trial. Diabetes Educator, 35(4), 641–651. DOI ↗ | Cox, D. J., Irvine, A., Gonder-Frederick, L., Nowacek, G., & Butterfield, G. (1987). Fear of hypoglycemia: Quantification, validation, and utilization. Diabetes Care, 10(5), 617–621. DOI ↗ |
| Outros nomes≠ | DASES | HFS, HFS-II |
| Relacionados | 3 | 3 |
| Resumo≠ | The Diabetes Self-Efficacy Scale (DASES) is an 8-item self-report measure that assesses a patient's confidence in their ability to manage key diabetes self-care tasks: medication adherence, glucose monitoring, diet management, exercise, and coping with symptoms or complications. Developed by Lorig and colleagues based on social-cognitive theory, the DASES is grounded in Bandura's self-efficacy framework and demonstrates strong predictive validity for glycemic control, treatment adherence, and quality of life outcomes. | The Hypoglycemia Fear Survey (HFS) is a self-report measure that quantifies fear of, anxiety about, and behavioral responses to hypoglycemia in patients with type 1 diabetes and insulin-treated type 2 diabetes. Originally developed by Cox and colleagues in 1987 and revised (HFS-II) in 1993, the HFS captures the emotional and behavioral impact of hypoglycemia risk, particularly the tendency to run higher blood glucose to avoid episodes, making it essential for understanding a major barrier to optimal glucose control in insulin-dependent diabetes. |
| ScholarGateConjunto de dados ↗ |
|
|